Sector valuations Cytokinetics, Incorporated
Equities
CYTK
US23282W6057
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.22 USD | +3.22% |
|
+3.94% | +21.53% |
| 05-11 | Cytokinetics Announces New Data Related to MYQORZO At ESC Heart Failure 2026 | CI |
| 05-07 | Cytokinetics Prices Upsized $700 Million Share Offering | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -12.17x | -119.04x | 10.09x | 84.04x | -11.54x | -11.47x | -.--% | 9.79B | ||
| 29.71x | 5.62x | 0.73x | 7.6x | 22.79x | 23.55x | 0.06% | 50.39B | ||
| 17.05x | 3.29x | -1.98x | 5.19x | 11.35x | 13.09x | 1.74% | 46.03B | ||
| -43.01x | 67.02x | 0.74x | 14.38x | -39.04x | -45.93x | -.--% | 25.06B | ||
| -18.29x | 1.07x | 2.2x | 3.39x | -6.18x | -4.88x | -.--% | 23.26B | ||
| 21.35x | 2.1x | 1.51x | 4.22x | 10.94x | 13.16x | -.--% | 17.24B | ||
| 22.89x | 2.56x | -0.94x | 4.47x | 14.74x | 16.59x | -.--% | 16.15B | ||
| 769.56x | 11.15x | -6.91x | 18.13x | 98.99x | 207.68x | -.--% | 14.56B | ||
| -15.7x | 186.89x | 0.8x | 4028.17x | -19.97x | -16.46x | -.--% | 14.08B | ||
| -438.46x | 17.92x | 9.23x | 31.36x | -1963.9x | -308.68x | -.--% | 12.94B | ||
| 16.18x | 4.58x | 1.19x | 4.65x | 10.9x | 12.01x | -.--% | 12.84B | ||
| -79.08x | 27.69x | 1.69x | 7.97x | -75.12x | -58.51x | -.--% | 12.45B | ||
| -25.55x | 21.93x | -0x | 22.29x | -31.16x | -24.29x | -.--% | 11.22B | ||
| 39.06x | 7.43x | 0.83x | 11.4x | 28.94x | 29.78x | 0.22% | 9.2B | ||
| 12.18x | 6.12x | 0.03x | 7.42x | 12.26x | 12.81x | -.--% | 8.42B | ||
| -9.76x | - | -0.08x | - | - | - | - | 8.54B | ||
| 31.77x | 5.19x | -2.53x | 7.17x | 27.88x | 31.81x | - | 8.79B | ||
| -18.22x | 6.98x | 8.86x | 593.6x | -17.2x | -16.98x | -.--% | 8.25B | ||
| -6.29x | - | -0.12x | - | -6.44x | -5.92x | -.--% | 7.73B | ||
| Average | 15.43x | 15.21x | 1.33x | 285.61x | -107.32x | -7.37x | 0.12% | 16.68B | |
| Weighted average by Cap. | 19.25x | 16.46x | 0.78x | 216.01x | -78.21x | -2.16x | 0.28% |
- Stock Market
- Equities
- CYTK Stock
- Sector Cytokinetics, Incorporated
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















